| 1. |
Concordance: is it just another version of compliance? |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1409,
2003,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 2. |
Focusing on stroke: management and prevention |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1409,
2003,
Page 3-3
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 3. |
Major pharmaceutical companies are turning away from antibacterial development, |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1409,
2003,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 4. |
Telithromycin potentially cost saving in patients with AECB |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1409,
2003,
Page 5-6
L Hunt,
Preview
|
|
摘要:
Chronic bronchitis is a highly prevalent disease affecting more than 14 million individuals in the US alone. Patients with chronic bronchitis frequently experience acute exacerbations of the condition, the clinical management of which confers a major clinical and economic burden on healthcare systems. Total healthcare costs associated with acute exacerbations of chronic bronchitis (AECB) have been estimated to cost $US1.7 billion annually in the US, with hospitalisation accounting for the largest share of this cost. Investigators from the US and Canada found that telithromycin has the potential to have a major effect on the cost of AECB in the US, and they presented their results at the 43rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) [Chicago, US; September 2003].1
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 5. |
Which screening test for diabetes best value in the US? |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1409,
2003,
Page 6-6
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 6. |
Pegvisomant reduces insulin requirements in type 1 diabetes |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1409,
2003,
Page 7-7
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 7. |
Darifenacin*may prolong "warning time" in overactive bladder (OAB) syndrome, |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1409,
2003,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 8. |
An oral insulin formulation, 'Oralin'*, significantly improves glucose control in patients with type 2 diabetes mellitus, |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1409,
2003,
Page 9-9
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 9. |
News from the XI Congress of the International Headache Society |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1409,
2003,
Page 10-12
RM Poole,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 10. |
Neutralising antibodies to interferon (IFN)-β in patients with multiple sclerosis (MS) affect clinical activity, |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1409,
2003,
Page 12-12
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
首页
